ARCHIVES

Revlimid Also Demonstrates Response in Mantle Cell

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989

DCPC Board Approves Concepts Of Six New RFAs Totaling $9.3 Million A Year

May 11, 1984

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

January 29, 1982